The above relevant policies are clear. Since March 1, 2019, general VAT taxpayers who produce, sell, wholesale and retail rare disease drugs can choose to pay VAT at a simple rate of 3%. The above taxpayers choose the simple method to calculate and pay VAT, which shall not be changed within 36 months. Starting from March 1, 2019, import value-added tax will be levied at a reduced rate of 3% on imported rare disease drugs.
Beijing Youth Daily reporter learned that the VAT reduction drugs include 45 kinds of anticancer drug preparations and raw materials, such as dacotinib tablets for non-small cell lung cancer, furquetinib capsules for metastatic colorectal cancer, and 14 rare disease drug preparations for multiple sclerosis, and nosinasheng sodium injection for spinal muscular atrophy u3002
Source: Zhang Zutao, editor in charge of Beijing Youth Daily_ NT5054